BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8535019)

  • 1. [In vitro effects of piracetam on the radiosensitivity of hypoxic cells (adaptation of MTT assay to hypoxic conditions)].
    Lagarde P; Gheuens EE; De Pooter CM; De Bruijn EA; van der Heyden S; Chomy F; Van Oosterom AT; Scalliet PG
    Bull Cancer; 1995 Nov; 82(11):929-38. PubMed ID: 8535019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between the clonogenic, MTT, and SRB assays for determining radiosensitivity in a panel of human bladder cancer cell lines and a ureteral cell line.
    Banasiak D; Barnetson AR; Odell RA; Mameghan H; Russell PJ
    Radiat Oncol Investig; 1999; 7(2):77-85. PubMed ID: 10333248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of micronucleus assay in radiosensitivity tests using human cancer cell lines].
    Kimura H
    Nihon Hinyokika Gakkai Zasshi; 1998 Aug; 89(8):712-20. PubMed ID: 9780656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MTT-hybrid assay incorporates the advantages of both clonogenic and MTT assay radiosensitivity testing for fresh tumor samples.
    Enomoto T; Takao S; Mure H; Baba M; Aikou T
    J Exp Clin Cancer Res; 1997 Sep; 16(3):273-80. PubMed ID: 9387901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of radiation survival using the MTT assay.
    Slavotinek A; McMillan TJ; Steel CM
    Eur J Cancer; 1994; 30A(9):1376-82. PubMed ID: 7999428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemosensitivity and radiosensitivity of small cell lung cancer cell lines studied by a newly developed 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) hybrid assay.
    Hida T; Ueda R; Takahashi T; Watanabe H; Kato T; Suyama M; Sugiura T; Ariyoshi Y; Takahashi T
    Cancer Res; 1989 Sep; 49(17):4785-90. PubMed ID: 2547517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The differential hypoxic cytotoxicity of bioreductive agents determined in vitro by the MTT assay.
    Stratford IJ; Stephens MA
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):973-6. PubMed ID: 2495261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the tetrazolium assay in measuring the response of human tumor cells to ionizing radiation.
    Price P; McMillan TJ
    Cancer Res; 1990 Mar; 50(5):1392-6. PubMed ID: 2302704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a colorimetric microtiter (MTT) assay in determining the radiosensitivity of cells from murine solid tumors.
    Wasserman TH; Twentyman P
    Int J Radiat Oncol Biol Phys; 1988 Sep; 15(3):699-702. PubMed ID: 3417490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictability of in vivo chemosensitivity by in vitro MTT assay with reference to the clonogenic assay.
    Shimoyama Y; Kubota T; Watanabe M; Ishibiki K; Abe O
    J Surg Oncol; 1989 May; 41(1):12-8. PubMed ID: 2716329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing.
    Carmichael J; DeGraff WG; Gazdar AF; Minna JD; Mitchell JB
    Cancer Res; 1987 Feb; 47(4):936-42. PubMed ID: 3802100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced chemosensitivity in acute myeloid leukemia by hematopoietic growth factors: a comparison of the MTT assay with a clonogenic assay.
    te Boekhorst PA; Löwenberg B; Sonneveld P
    Leukemia; 1993 Oct; 7(10):1637-44. PubMed ID: 7692194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A modified computer-assisted colorimetric microtitre assay (MTT) to assess in vitro radiosensitivity of V79, CaSki, HeLa and WiDr cells.
    Eble MJ; Hensley FW; Flentje M; Schlotz A; Wannenmacher M
    Int J Radiat Biol; 1994 Feb; 65(2):193-201. PubMed ID: 7907117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a rapid tetrazolium-based colorimetric assay for selecting anticancer drugs.
    Chen CF; Hwang JM; Wu CH; Chen CS; Chen KY
    Zhonghua Yi Xue Za Zhi (Taipei); 1990 Jul; 46(1):7-16. PubMed ID: 2176928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the MTT assay to human prostate cancer cell lines in vitro: establishment of test conditions and assessment of hormone-stimulated growth and drug-induced cytostatic and cytotoxic effects.
    Romijn JC; Verkoelen CF; Schroeder FH
    Prostate; 1988; 12(1):99-110. PubMed ID: 3126493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oleanolic acid enhances the radiosensitivity of tumor cells under mimetic hypoxia through the reduction in intracellular GSH content and HIF-1α expression.
    Qi R; Jin W; Wang J; Yi Q; Yu M; Xu S; Jin W
    Oncol Rep; 2014 May; 31(5):2399-406. PubMed ID: 24604140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of MTT and ATP-based assays for the measurement of viable cell number.
    Petty RD; Sutherland LA; Hunter EM; Cree IA
    J Biolumin Chemilumin; 1995; 10(1):29-34. PubMed ID: 7762413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxic mammalian cell radiosensitization by nitric oxide.
    Mitchell JB; Wink DA; DeGraff W; Gamson J; Keefer LK; Krishna MC
    Cancer Res; 1993 Dec; 53(24):5845-8. PubMed ID: 8261391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosensitizing effect of irisquinone on glioma through the downregulation of HIF-1α evaluated by 18F-FDG and 18F-FMISO PET/CT.
    Wang H; Zhang Y; Yu W; Zhao X; Xue Y; Xu H
    Nucl Med Commun; 2016 Jul; 37(7):705-14. PubMed ID: 26963468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transportable system enabling multiple irradiation studies under simultaneous hypoxia in vitro.
    Metsälä O; Kreutzer J; Högel H; Miikkulainen P; Kallio P; Jaakkola PM
    Radiat Oncol; 2018 Nov; 13(1):220. PubMed ID: 30424810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.